As those figures roll into the denominator, headline growth rates are likely to decelerate even if absolute GLP-1 sales continue to expand
~ AlphaMD Here's the thing about aromatase inhibitors - everyone's got an opinion, but most guys are either using them when they shouldn't or skipping them when they definitely should
Org Proc Res Dev 23:27462753 Guryanov I, Orlandin A, Viola A, Biondi B, Formaggio F, Ricci A, Cabri W (2020) Overcoming Chemical Challenges in the Solid-Phase Synthesis of High-Purity GnRH Antagonist Degarelix
These are known as off-label uses because they are not the primary reasons for which the drug was approved by the FDA
Nle-AngIV also increased spine numbers to 32 spines/50m, but to a lesser extent than Dihexa
Most medication PA delays trace to six causes: incomplete documentation at submission, manual fax submission instead of electronic, step therapy requirements not documented, payer-specific criteria not addressed, authorization numbers missing from claims, and insufficient PA staffing capacity
